Almac Pharma Services Extends UK Facilities

Almac Pharma Services are extending their formulation facilities with the opening of a refurbished 10,500-sq.-ft. building at the company’s UK headquarters. The company invested $10.5 million to strengthen its offering to the global pharma and biopharma industries.

The custom-designed facility will operate to full cGMP, providing extended formulation development services in solid oral dosage forms from pre-clinical through to pilot scale. This advancement will provide classified facilities (ISO 8 / Class 100,000) including labs with independent temperature and humidity controlled zones and self-contained suites—many with high containment capabilities.

Graeme McBurney M.D., Almac Pharma Services president, said the investment represents a significant element of the overall future growth strategy of Pharma Services. “We at Almac Pharma Services are entering into a new and exciting phase in our development. We are investing to expand the breadth and depth of an already comprehensive suite of commercial services. We work with an increasing number of clients, supporting their needs at each stage of the drug product life cycle, including formulation development, clinical batch production, commercial scale manufacturing, packaging and global supply chain management.”